Impact of renin-angiotensin-aldosterone system gene polymorphisms on left ventricular dysfunction in coronary artery disease patients

Disease Markers

Volumn 32, Issue 1, 2012, Pages 33-41

  Mishra, Avshesh ^a   Srivastava, Anshika ^a   Mittal, T ^a   Garg, N ^a   Mittal, B ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Coronary artery disease; LVD; LVEF; RAAS genetic variants

Indexed keywords

ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ANGIOGRAPHY; ARTICLE; CARDIAC PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE REPLICATION; GENETIC VARIABILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84856645291     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2012-0858     Document Type: Article

References (38)

1. R. McPherson, A. Pertsemlidis, N. Kavaslar et al., A common allele on chromosome 9 associated with coronary heart disease, Science 316 (2007), 1488-1491. (Pubitemid 46906617)
2. M. Zakrzewski-Jakubiak, S. deDenus, M.P. Dube, F. Belanger, M. White and J. Turgeon, Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure, Br J Clin Pharmacol 65 (2008), 742-751. (Pubitemid 351545791)
3. F. Triposkiadis, G. Karayannis, G. Giamouzis, J. Skoularigis, G. Louridas and J. Butler, The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications, J Am Coll Cardiol 54 (2009), 1747-1762.
4. L. Tiret, A. Bonnardeaux, O. Poirier et al., Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction, Lancet 344 (1994), 910-913. (Pubitemid 24295876)
5. A.P. Pilbrow, B.R. Palmer, C.M. Frampton et al., An-giotensinogen M235T and T174M gene polymorphisms in combination doubles the risk of mortality in heart failure, Hypertension 49 (2007), 322-327. (Pubitemid 46143008)
6. B. Devlin and K. Roeder, Genomic control for association studies, Biometrics 55 (1999), 997-1004.
7. P.P. Rickham, Human Experimentation. Code of Ethics of the World Medical Association, Declaration of Helsinki, Br Med J 2 (1964), 177.
8. N.B. Schiller, P.M. Shah, M. Crawford et al., Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms, J Am Soc Echocardiogr 2 (1989), 358-367.
9. R. Johnson, P. McNutt, S. MacMahon and R. Robson, Use of the Friedewald Formula to Estimate LDL-Cholesterol in Patients with Chronic Renal Failure on Dialysis, Clin Chem 43 (1997), 2183-2184. (Pubitemid 27497820)
10. S.A. Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res 16 (1988), 1215.
11. G. Joshi, S. Pradhan and B. Mittal, Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population, J Neurol Sci 277 (2009), 133-137.
12. Shu Ye SDXK, A.R Collins and I.N.M Day, An efficient procedure for genotyping single nucleotide polymorphisms, Nucleic Acids Research (2001), 29.
13. A.H. Markku Kupari, L. Lankinen, P. Koskinen, J. Virolainen, H. Nikkila and P.C. White, Associations Between Human Aldosterone Synthase (CYP11B2) Gene Polymorphisms and Left Ventricular Size, Mass, and Function, Circulation 97 (1998), 569-575. (Pubitemid 28090686)
14. P.W. Armstrong, Left ventricular dysfunction: causes, natural history, and hopes for reversal, Heart 84(Suppl 1) (2000), i15-17: discussion i50.
15. R. Alvarez, J.R. Reguero, A. Batalla et al., Angiotensin-converting enzyme and angiotensin II receptor 1 polymor-phisms: association with early coronary disease, Cardiovasc Res 40 (1998), 375-379. (Pubitemid 28506048)
16. I. Canavy, M. Henry, P.E. Morange et al., Genetic polymorphisms and coronary artery disease in the south of France, Thromb Haemost 83 (2000), 212-216. (Pubitemid 30093221)
17. G.K. Andrikopoulos, D.J. Richter, E.W. Needham et al., The paradoxical association of common polymorphisms of the renin-angiotensin system genes with risk of myocardial infarction, Eur J Cardiovasc Prev Rehabil 11 (2004), 477-483. (Pubitemid 40096849)
18. M.A. Araujo, B.S. Menezes, C. Lourenco, E.R. Cordeiro, R.R. Gatti and L.R. Goulart, The A1166C polymorphism of the angiotensin II type-1 receptor in acute myocardial infarction, Arq Bras Cardiol 83 (2004), 409-413; 404-408.
19. Y. Liu, C. Zhuoma, G. Shan et al., A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populations, Hypertens Res 25 (2002), 515-521.
20. Y. Liu, G.L. Shan, C.Y. Cui et al., A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populations, Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20 (2003), 220-224. (Pubitemid 36717962)
21. J. Diez, C. Laviades, J. Orbe et al., The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives, J Hypertens 21 (2003), 2085-2092. (Pubitemid 38296870)
22. A.P. Osterop, M.J. Kofflard, L.A. Sandkuijl et al., AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy, Hypertension 32 (1998), 825-830. (Pubitemid 28530214)
23. P. Sethupathy, C. Borel, M. Gagnebin et al., Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes, Am J Hum Genet 81 (2007), 405-413. (Pubitemid 47236088)
24. M. Maczewski, J. Maczewska and M. Duda, Hypercholestero-laemia exacerbates ventricular remodelling after myocardial infarction in the rat: role of angiotensin II type 1 receptors, Br J Pharmacol 154 (2008), 1640-1648.
25. F. Cambien and A. Evans, Angiotensin I converting enzyme gene polymorphism and coronary heart disease, Eur Heart J 16(Suppl K) (1995), 13-22. (Pubitemid 26031509)
26. B. Keavney, C. McKenzie, S. Parish et al., Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and my-ocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators, Lancet 355 (2000), 434-442. (Pubitemid 30085151)
27. K. Lindpaintner, M.A. Pfeffer, R. Kreutz et al., A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease, N Engl J Med 332 (1995), 706-711.
28. J.C. Rodriguez-Perez, F. Rodriguez-Esparragon, O. Hernan-dez-Perera et al., Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene, J Am Coll Cardiol 37 (2001), 1536-1542.
29. J. Ruiz, H. Blanche, H. Cohen et al., Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus, Proc Natl Acad Sci USA 91 (1994), 3662-3665. (Pubitemid 24139491)
30. N.J. Samani, J.R. Thompson, L. O'Toole, K. Channer and K.L. Woods, A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction, Circulation 94 (1996), 708-712. (Pubitemid 26289226)
31. J. Parenica, M.P. Goldbergova, P. Kala et al., ACE gene insertion/deletion polymorphism has a mild influence on the acute development of left ventricular dysfunction in patients with ST elevation myocardial infarction treated with primary PCI, BMC Cardiovasc Disord 10, 60.
32. E. Brand, N. Chatelain, P. Mulatero et al., Structural analysis and evaluation of the aldosterone synthase gene in hypertension, Hypertension 32 (1998), 198-204. (Pubitemid 28376473)
33. M. Matsubara, T. Sato, T. Nishimura et al., CYP11B2 polymorphisms and home blood pressure in a population-based cohort in Japanese: the Ohasama study, Hypertens Res 27 (2004), 1-6. (Pubitemid 38208415)
34. H. Schunkert, S.R. Holmer, U. Broeckel, A. Luchner, M.W. Muscholl et al., Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure, Circulation 99 (1999), 2255-2260. (Pubitemid 29201131)
35. L. Tiret, O. Poirier, V. Nicaud, A. Millaire, J.B. Bouhour et al., Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study, J Am Coll Cardiol 35 (2000), 29-35. (Pubitemid 30061255)
36. E. Davies, C.D. Holloway, M.C. Ingram et al., Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2, Hypertension 33 (1999), 703-707. (Pubitemid 29091652)
37. C. Rajput, T. Nnorboo, F. Afrin, M. Sharma, S.T. Pasha et al., CYP11B2 gene polymorphisms and hypertension in highlanders accustomed to high salt intake, J Hypertens 23 (2005), 79-86. (Pubitemid 40128984)
38. I. Komiya, M. Takara, T. Asawa, M. Shimabukuro, T. Nnishi-mori et al., Lys(173)Arg and-344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension, Hypertension 35 (2000), 699-703. (Pubitemid 30165312)